A substantial insider activity was disclosed on May 28, as Bierbower, Board Member at Progyny PGNY, reported the exercise of a large sell of company stock options.
What Happened: In an insider options sale disclosed in a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission, Bierbower, Board Member at Progyny, exercised stock options for 0 shares of PGNY. The transaction value amounted to $0.
The Wednesday morning market activity shows Progyny shares down by 0.0%, trading at $20.59. This implies a total value of $0 for Bierbower’s 0 shares.
All You Need to Know About Progyny
Progyny Inc is a benefits management company specializing in fertility, family building, and women’s health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny’s Financial Performance
Revenue Growth: Progyny’s remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 16.53%. This signifies a substantial increase in the company’s top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Profitability Metrics: Unlocking Value
-
Gross Margin: The company faces challenges with a low gross margin of 23.39%, suggesting potential difficulties in cost control and profitability compared to its peers.
-
Earnings per Share (EPS): With an EPS below industry norms, Progyny exhibits below-average bottom-line performance with a current EPS of 0.18.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.06.
Analyzing Market Valuation:
-
Price to Earnings (P/E) Ratio: Progyny’s stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 36.12.
-
Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.57, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
-
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Progyny’s EV/EBITDA ratio stands at 20.02, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
Exploring the legal landscape, an “insider” is defined as any officer, director, or beneficial owner holding more than ten percent of a company’s equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider’s new purchase, there’s a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
Breaking Down the Significance of Transaction Codes
When dissecting transactions, the focal point for investors is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Progyny’s Insider Trades.
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don’t miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Add Comment